| Literature DB >> 30596738 |
Bas Brinkhof1, Huidong Jia1, Bo Zhang1, Zhanfeng Cui1, Hua Ye1, Hui Wang1.
Abstract
Human Multipotent Stromal Cells (MSCs) are a valuable resource for regenerative medicine and are widely studied. They can be isolated from a variety of tissues and differentiate into multiple cell types (multi-potent). Many reports have been published using human MSCs and to be able to compare outcome, or be able to identify differences between MSCs, several cell surface markers have been proposed. Nevertheless, still many differences remain. Gene expression is known to be different between cell stage and origin. Furthermore, cells cultured on a culture dish (2D) show different gene expression profiles as compared to cells grown on scaffolds (3D). Even the RNA extraction method and the selection of genes used for normalisation have a role in gene expression profiling. To be able to compare gene expression data from samples cultured in different dimensions and RNA extracted using a variety of protocols we set out to define a set of reference genes suitable to normalise qPCR data from a very heterogeneous sample set. Hereto, Trizol was used to extract RNA from human MSCs cultured in 3D and 2D to validate newly designed and previously published primer sets. Subsequently, RNA from fresh human MSC samples and samples stored in RLT-buffer, Trizol or RNAlater was extracted using RNeasy and Trizol methods. All samples have been used to rank the candidate reference genes according to their stability after qPCR enabling identification of the most suitable reference gene(s) for normalisation of a heterogeneous sample set. The most stably expressed reference genes indicated superior normalisation of MSC marker gene expression over the least stable reference genes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30596738 PMCID: PMC6312307 DOI: 10.1371/journal.pone.0209772
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primer properties and in silico evaluation.
| Gene | Gene full name | Acc # | isoforms | PGs | Primer sequence | Exon | Location | amplicon size (bp) | mFOLD at Ta | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | D | PC | PCD | |||||||||
| ACTB | actin beta | NM_001101 | 19 | 9 | 11 | 5 | 18 | 3 | 420–437 | 189 | -1.43 | |
| 4 | 591–608 | |||||||||||
| B2M | beta-2-microglobulin | NM_004048 | 14 | 7 | 3 | 3 | 0 | 1 | 50–65 | 224 | -0.22 | |
| 2 | 253–273 | |||||||||||
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | NM_002046 | 11 | 10 | 6 | 5 | 64 | 3 | 104–121 | 205 | 0.13 | |
| 4 | 290–308 | |||||||||||
| GUSB | glucuronidase beta | NM_000181 | 14 | 5 | 2 | 2 | 18 | 1 | 168–183 | 218 | -3.60 | |
| 2 | 366–385 | |||||||||||
| HMBS | hydroxymethylbilane synthase | NM_000190 | 26 | 16 | 11 | 8 | 0 | 1 | 156–173 | 142 | 0.47 | |
| 3 | 278–297 | |||||||||||
| HPRT1(15) | hypoxanthine phosphoribosyltransferase 1 | NM_000194 | 3 | 3 | 1 | 1 | 3 | 4 | 489–508 | 132 | 0.73 | |
| 6 | 601–620 | |||||||||||
| PPIA(11) | peptidylprolyl isomerase A | NM_021130 | 10 | 6 | 5 | 4 | 79 | 1 | 93–112 | 97 | -1.20 | |
| 2 | 169–189 | |||||||||||
| PUM1 | pumilio RNA binding family member 1 | NM_001020658 | 23 | 9 | 13 | 8 | 0 | 14 | 2371–2390 | 196 | -2.19 | |
| 15 | 2548–2566 | |||||||||||
| RPL13A | ribosomal protein L13a | NM_012423 | 14 | 9 | 3 | 2 | 25 | 1 | 25–45 | 187 | -2.46 | |
| 3 | 191–211 | |||||||||||
| RPLP0(11) | ribosomal protein lateral stalk subunit P0 | NM_053275 | 27 | 10 | 12 | 5 | 12 | 6 | 805–824 | 214 | -0.91 | |
| 7 | 998–1018 | |||||||||||
| TBP | TATA-box binding protein | NM_003194 | 8 | 6 | 7 | 5 | 0 | 2 | 284–302 | 113 | -0.13 | |
| 3 | 377–396 | |||||||||||
| TFRC | transferrin receptor | NM_003234 | 15 | 2 | 4 | 2 | 0 | 3 | 356–374 | 234 | 0.00 | |
| 4 | 571–589 | |||||||||||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | NM_145690 | 23 | 14 | 18 | 11 | 11 | 2 | 381–399 | 180 | -0.04 | |
| 3 | 541–560 | |||||||||||
| ENG | endoglin | NM_001114753 | 5 | 2 | 3 | 2 | 0 | 12 | 238 | |||
| 14/15 | ||||||||||||
| NT5E | 5'-nucleotidase ecto | NM_002526 | 5 | 1 | 5 | 1 | 0 | 7 | 175 | |||
| 8 | ||||||||||||
| THY1 | Thy-1 cell surface antigen | NM_006288 | 10 | 8 | 5 | 3 | 0 | 2 | 230 | |||
| 3 | ||||||||||||
Details of primers used in this manuscript.
aPreviously published primer sets are referenced. All others have been newly designed.
bAccording to Ensemble.com (D = detectable with designed primers; PC = Protein Coding; PCD = Detectable PC with designed primers)
cPGs = Known pseudogenes. According to NCBI Gene database
dIn case of multiple possible structures the most negative value is given; Bold = in primer annealing region 3’/5’.
Fig 1Flow cytometry analyses of UCMSC surface markers.
Fluorescently-labelled antibodies were used to detect CD73, CD90, CD105, CD31, and CD34 expression levels by flow cytometry. The results indicated the genuine MSC character expected for cells derived from umbilical cord (UC). Error bars indicate standard deviation.
Sample diversity.
| Sample Name | Cell # at start culture | Culture time (days) | Cell isolation | Storage compound | Storage time (days) | Storage temp. (°C) | Extraction method | RNA total (μg) | A260/A280 | A260/A230 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3D Fib-Alg 1 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 7.51 | 1.477 | 0.389 |
| 2 | 3D Fib-Alg 2 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 9.67 | 1.487 | 0.448 |
| 3 | 3D Fib-Alg 3 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 10.42 | 1.495 | 0.424 |
| 4 | 3D Fib 1 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 12.43 | 1.519 | 0.380 |
| 5 | 3D Fib 2 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 12.42 | 1.524 | 0.406 |
| 6 | 3D Fib 3 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 12.55 | 1.553 | 0.394 |
| 7 | Cells 48w 1 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 12.27 | 1.520 | 0.412 |
| 8 | Cells 48w 2 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 14.92 | 1.536 | 0.432 |
| 9 | Cells 48w 3 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 9.84 | 1.467 | 0.403 |
| 10 | Beads 1 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 12.97 | 1.507 | 0.442 |
| 11 | Beads 2 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 12.07 | 1.513 | 0.418 |
| 12 | Beads 3 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 10.39 | 1.484 | 0.411 |
| 13 | Cells 12w 1 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 7.50 | 1.490 | 0.504 |
| 14 | Cells 12w 2 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 8.47 | 1.461 | 0.392 |
| 15 | Cells 12w 3 | 5.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 12.52 | 1.541 | 0.433 |
| 16 | I.A3 | 1.00E+05 | 3 | RLT | RLT | 0 | N/A | Rneasy | 2.16 | 2.018 | 1.550 |
| 17 | I.B4 | 1.00E+05 | 3 | RLT | RLT | 7 | -80 | Rneasy | 2.52 | 2.047 | 1.563 |
| 18 | I.B3 | 1.00E+05 | 3 | RLT | RLT | 7 | -20 | Rneasy | 2.46 | 2.053 | 1.237 |
| 19 | I.C4 | 1.00E+05 | 3 | RLT | RLT | 30 | -80 | Rneasy | 2.13 | 2.272 | 0.061 |
| 20 | I.C3 | 1.00E+05 | 3 | RLT | RLT | 30 | -20 | Rneasy | 2.83 | 2.095 | 0.421 |
| 21 | I.A2 | 1.00E+05 | 3 | Trizol | Trizol | 0 | N/A | Trizol | 1.93 | 2.125 | 1.088 |
| 22 | I.B2 | 1.00E+05 | 3 | Trizol | Trizol | 7 | -80 | Trizol | 2.65 | 2.056 | 1.931 |
| 23 | I.B1 | 1.00E+05 | 3 | Trizol | Trizol | 7 | -20 | Trizol | 1.16 | 2.054 | 1.362 |
| 24 | I.C2 | 1.00E+05 | 3 | Trizol | Trizol | 30 | -80 | Trizol | 0.92 | 2.035 | 0.669 |
| 25 | I.C1 | 1.00E+05 | 3 | Trizol | Trizol | 30 | -20 | Trizol | 3.28 | 2.046 | 1.564 |
| 26 | II.A3 | 1.00E+05 | 3 | Trypsin | RLT | 0 | N/A | Rneasy | 2.39 | 2.046 | 1.730 |
| 27 | II.B4 | 1.00E+05 | 3 | Trypsin | RLT | 7 | -80 | Rneasy | 2.73 | 2.105 | 1.345 |
| 28 | II.B3 | 1.00E+05 | 3 | Trypsin | RLT | 7 | -20 | Rneasy | 3.51 | 2.081 | 1.804 |
| 29 | II.C4 | 1.00E+05 | 3 | Trypsin | RLT | 30 | -80 | Rneasy | 1.69 | 2.156 | 0.679 |
| 30 | II.C3 | 1.00E+05 | 3 | Trypsin | RLT | 30 | -20 | Rneasy | 2.59 | 2.092 | 1.031 |
| 31 | III.B4 | 1.00E+05 | 3 | Trypsin | RNAlater | 7 | -80 | Rneasy | 1.47 | 2.160 | 0.991 |
| 32 | III.B3 | 1.00E+05 | 3 | Trypsin | RNAlater | 7 | -20 | Rneasy | 1.99 | 2.059 | 1.261 |
| 33 | III.C4 | 1.00E+05 | 3 | Trypsin | RNAlater | 30 | -80 | Rneasy | 1.24 | 2.134 | 0.597 |
| 34 | III.C3 | 1.00E+05 | 3 | Trypsin | RNAlater | 30 | -20 | Rneasy | 1.42 | 2.126 | 0.587 |
| 35 | III.B2 | 1.00E+05 | 3 | Trypsin | RNAlater | 7 | -80 | Trizol | 0.02 | 27.025 | 0.034 |
| 36 | III.B1 | 1.00E+05 | 3 | Trypsin | RNAlater | 7 | -20 | Trizol | 1.80 | 2.071 | 1.517 |
| 37 | III.C2 | 1.00E+05 | 3 | Trypsin | RNAlater | 30 | -80 | Trizol | 1.21 | 1.969 | 0.990 |
| 38 | III.C1 | 1.00E+05 | 3 | Trypsin | RNAlater | 30 | -20 | Trizol | 2.54 | 2.041 | 1.624 |
| 39 | II.A2 | 1.00E+05 | 3 | Trypsin | Trizol | 0 | N/A | Trizol | 2.88 | 2.021 | 1.540 |
| 40 | II.B2 | 1.00E+05 | 3 | Trypsin | Trizol | 7 | -80 | Trizol | 2.93 | 2.069 | 1.861 |
| 41 | II.B1 | 1.00E+05 | 3 | Trypsin | Trizol | 7 | -20 | Trizol | 1.68 | 2.026 | 1.449 |
| 42 | II.C2 | 1.00E+05 | 3 | Trypsin | Trizol | 30 | -80 | Trizol | 1.42 | 2.045 | 1.706 |
| 43 | II.C1 | 1.00E+05 | 3 | Trypsin | Trizol | 30 | -20 | Trizol | 3.10 | 2.044 | 2.017 |
Samples were obtained from MSC-hTERT (1–15) and UC-MSC (16–43) cultured at different cell densities, stored at different temperatures and time, and using different extraction methods. Yield, A260/280, and A260/A230 ratios are given. N/A; Not Applicable.
Fig 2Cells cultured in 3D scaffolds and 2D monolayer culture dish.
Cells cultured in fibrinogen-alginate (3D Fib-Al) and fibrinogen (3D Fib) scaffolds, on PCL-PNIPAAM (Beads) or in 48 well (Cells 48w) and 12 well (Cells 12w) culture plates (All n = 3) were stained for their viability with Alamar Blue (A). Arbitrary units are given on the y-axis. RNA concentration (B) from Trizol extraction for the same samples is given (μg) on the y-axis. Error bars represent the standard deviation. Gel electrophoresis (C) indicated separation of the 28S and 18S RNA units in most samples (locations indicated by closed or open arrow, resp.). Sample lanes are flanked by a 1kb DNA ladder (M).
Fig 3Primer efficiency and gene quantity.
All genes could be detected by their respective primer sets (A) of which most were within the set efficiency range of 90–110% (B). Dotted lines define efficiency boundaries and the solid line represents 100% efficiency. Only HMBS had a too low efficiency (< 90% which is represented as an open dot). The length of the formed product (amplicon) does not have linear correlation to the efficiency (C; r2 = 0.007705, p = 0.7755) or to the abundancy indicated by the Cq of the first standard (D; r2 = 0.03130, p = 0.5631). Primer sets potentially having annealing difficulties caused by possible folding of the amplicon as indicated by mFold analysis (Table 1) are depicted as open triangles.
Primer set validation.
| Gene | Optimal reaction Ta (°C) | amplicon Tm (°C) | Eff (%) | r2 | Cq St1 | Cq St5 | NTC (Cq) |
|---|---|---|---|---|---|---|---|
| ACTB | 60 | 88 | 91.56 | 0.9889 | 13.43 | 22.23 | 31.49 |
| B2M | 60 | 83 | 91.04 | 0.9982 | 16.49 | 24.93 | 37.08 |
| GAPDH | 64 | 84 | 95.35 | 0.9942 | 19.43 | 27.56 | ND |
| GUSB | 62 | 92 | 102.53 | 0.9652 | 27.98 | 36.42 | 37.09 |
| HMBS | 62 | 86.5 | 64.08 | 0.9643 | 25.44 | 37.08 | ND |
| HPRT1(15) | 66 | 80 | 101.95 | 0.9965 | 25.88 | 33.65 | ND |
| PPIA(11) | 62 | 86.5 | 97.07 | 0.9993 | 20.69 | 28.93 | ND |
| PUM1 | 66 | 87 | 93.02 | 0.9957 | 25.94 | 34.25 | ND |
| RPL13A | 66 | 89.5 | 100.18 | 0.9696 | 28.6 | 37.04 | ND |
| RPLP0(11) | 62 | 85 | 100.69 | 0.9980 | 13.82 | 21.65 | 37.15 |
| TBP | 64 | 85 | 106.21 | 0.9901 | 23.62 | 31.16 | 33.96 |
| TFRC | 62 | 82.5 | 100.14 | 0.9974 | 24.97 | 33.08 | ND |
| YWHAZ | 64 | 82 | 97.05 | 0.9951 | 22.66 | 30.91 | ND |
| ENG | 64 | 88.0 | 101.87 | 0.9253 | 21.85 | 31.63 | ND |
| NT5E | 64 | 86.0 | 98.29 | 0.9921 | 19.66 | 27.21 | ND |
| THY1 | 65 | 88.0 | 95.39 | 0.9966 | 23.80 | 31.78 | ND |
Experimental data per primer set (further in silico information is given in Table 1).
aReferences of previously reported primer sets are given unless newly developed. ND; Not Detected
Fig 4Gene expression and stability.
Gene expression detection range (Cq) was analyzed (A) in 2D UC-MSC (blue; n = 27), 2D cultured MSC-hTERT (green; n = 6) and 3D cultured MSC-hTERT (red; n = 9) samples. Samples with no Cq-values (number states amount) are shown as Cq > 40 (diamonds). Black, dotted line is maximum cycles in qPCR run. Boxes represent interquartile range (IQR = Q1 –Q3). Single, triangles represent outliers (Q3+1.5xIQR or Q1-1.5xIQR) if present. Whiskers represent maximum and minimum value after omitting outliers. Means are depicted by dots and medians by horizontal lines in the boxes. Gene expression stability according to Genorm (B), BestKeeper (C), Normfinder (D), and the Delta Ct method (E) were determined as well as the overall comprehensive ranking (F). Comprehensive rankings for all UC-MSC samples (G), only the 2D cultured MSC-hTERT (H), only 3D cultured hMSC-hTERT samples (I), all 2D cultured samples (J), and all hMSC-hTERT samples (K) were calculated using RefFinder.
Fig 5Relative grouped-correlation for each sample against the three different sample groups.
The data normalised against the three most stable reference genes is shown in a), represented by solid spheres. The data normalised against the three least stable reference genes is shown in b), represented by asterisks. Colour coding for the three groups: Blue, 2D UC-MSC; green, 2D MSC-hTERT; red, 3D MSC-hTERT.
Coefficient of variance for the grouped-correlation coefficients in each of the three sample groups.
| Most Stable | Least Stable | TBP+YWHAZ | single-TBP | single-YWHAZ | |
|---|---|---|---|---|---|
| 2D UC-MSC | 0.075 | 0.623 | 0.027 | 0.136 | 0.014 |
| 2D MSC-hTERT | 0.013 | 0.032 | 0.006 | 0.012 | 0.002 |
| 3D MSC-hTERT | 0.029 | 0.038 | 0.012 | 0.042 | 0.008 |
The coefficient of variance data normalised against different sets of reference genes is shown in each column.